Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fructose 1,6-Bisphosphate Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 99Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Beta-d-fructose 1,6-bisphosphate, Fructose-1,6-diphosphate, Beta-d-fructofuranose 1,6-bisphosphate, Beta-fructose-1,6-diphosphate, 34693-15-7, Fbp
    Molecular Formula
    C6H14O12P2
    Molecular Weight
    340.12  g/mol
    InChI Key
    RNBGYGVWRKECFJ-ARQDHWQXSA-N
    FDA UNII
    WCH874XLB1
    Fructose-1,6-bisphosphate is a metabolite found in the aging mouse brain.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate
    2.1.2 InChI
    InChI=1S/C6H14O12P2/c7-4-3(1-16-19(10,11)12)18-6(9,5(4)8)2-17-20(13,14)15/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/t3-,4-,5+,6-/m1/s1
    2.1.3 InChI Key
    RNBGYGVWRKECFJ-ARQDHWQXSA-N
    2.1.4 Canonical SMILES
    C(C1C(C(C(O1)(COP(=O)(O)O)O)O)O)OP(=O)(O)O
    2.1.5 Isomeric SMILES
    C([C@@H]1[C@H]([C@@H]([C@](O1)(COP(=O)(O)O)O)O)O)OP(=O)(O)O
    2.2 Other Identifiers
    2.2.1 UNII
    WCH874XLB1
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Fructose 1,6-bisphosphate

    2. Fructose 1,6-diphosphate

    3. Fructose-1,6-diphosphate

    4. Fructose-1,6-diphosphate Magnesium Salt

    5. Fructose-1,6-diphosphate, (alpha-d)-isomer

    6. Fructose-1,6-diphosphate, (beta-d)-isomer

    7. Fructose-1,6-diphosphate, (l)-isomer

    8. Fructose-1,6-diphosphate, 2-(18)o-labeled

    9. Fructose-1,6-diphosphate, Barium (1:2) Salt

    10. Fructose-1,6-diphosphate, Calcium (1:2) Salt

    11. Fructose-1,6-diphosphate, Calcium Salt

    12. Fructose-1,6-diphosphate, Disodium Salt

    13. Fructose-1,6-diphosphate, Monosodium Salt

    14. Fructose-1,6-diphosphate, Sodium Salt, Monohydrate

    15. Fructose-1,6-diphosphate, Tetrapotassium Salt

    16. Fructose-1,6-diphosphate, Tetrasodium Salt

    17. Fructose-1,6-diphosphate, Trisodium Salt

    18. Sr-fdp

    19. Strontium Fructose 1,6-diphosphate

    20. Strontium Fructose-1,6-diphosphate

    2.3.2 Depositor-Supplied Synonyms

    1. Beta-d-fructose 1,6-bisphosphate

    2. Fructose-1,6-diphosphate

    3. Beta-d-fructofuranose 1,6-bisphosphate

    4. Beta-fructose-1,6-diphosphate

    5. 34693-15-7

    6. Fbp

    7. Fructose 1,6-diphosphate

    8. Chebi:28013

    9. Fructose 1,6-bisphosphate

    10. Fructose-1,6-bisphosphate

    11. D-fructose-1,6-diphosphate

    12. Esafosfan

    13. Beta-d-fructofuranose 1,6-bis(dihydrogen Phosphate)

    14. Diphosphofructose

    15. [(2r,3s,4s,5r)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl Dihydrogen Phosphate

    16. D-fructose 1,6-biphosphate

    17. 488-69-7

    18. Ncgc00166321-01

    19. Fructose Bisphosphate

    20. Fructose 1,6-bis

    21. Esafosfina

    22. Beta Fructose 1,6-diphosphate

    23. 1bo5

    24. Bmse000011

    25. Wch874xlb1

    26. D-fructose 1,6-diphosphate

    27. D-fructose-1,6-bisphosphate

    28. Chembl97893

    29. Schembl168244

    30. .beta.-d-fructofuranose, 1,6-bis(dihydrogen Phosphate)

    31. Dtxsid0048347

    32. Beta-d-fructose-1,6-diphosphate

    33. .beta.-d-fosfructofuranose

    34. Zinc4096694

    35. Einecs 251-977-7

    36. Db04551

    37. C05378

    38. .beta.-d-fructofuranose 1,6-diphosphate

    39. Q414945

    40. Beta-d-fructofuranose, 1,6-bis(dihydrogen Phosphate)

    41. Beta-d-fructofuranose 1,6-bisphosphate (rssr Closed Ring)

    42. 16eb39bb-b854-429f-972f-0d8401178a36

    43. Wurcs=2.0/1,1,0/[ha122h-2b_2-5_1*opo/3o/3=o_6*opo/3o/3=o]/1/

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 340.12 g/mol
    Molecular Formula C6H14O12P2
    XLogP3-5.6
    Hydrogen Bond Donor Count7
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count6
    Exact Mass339.99604987 g/mol
    Monoisotopic Mass339.99604987 g/mol
    Topological Polar Surface Area203 Ų
    Heavy Atom Count20
    Formal Charge0
    Complexity428
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Arrhythmia Agents

    Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

    Cardiovascular Agents

    Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)

    Immunologic Factors

    Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)

    Neuroprotective Agents

    Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)

    4.2 ATC Code

    C - Cardiovascular system

    C01 - Cardiac therapy

    C01E - Other cardiac preparations

    C01EB - Other cardiac preparations

    C01EB07 - Fructose 1,6-diphosphate